| Recruiting | A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Rel Multiple Myeloma | Phase 3 | 2026-03-09 |
| Recruiting | A Study of GR1803 in Systemic Lupus Erythematosus Systemic Lupus Erthematosus, Auto Immune Disease | Phase 1 / Phase 2 | 2026-02-02 |
| Not Yet Recruiting | A Study to Evaluate the Safety of GR2301 Injection in Healthy Volunteers. Single Ascending Dose, Healthy Subjects | Phase 1 | 2025-10-10 |
| Not Yet Recruiting | A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis. Allergic Rhinitis, Seasonal | Phase 3 | 2025-09-25 |
| Recruiting | A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2303 in Healthy Adult Health Adult Subjects | Phase 1 | 2025-09-18 |
| Not Yet Recruiting | A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participant Multiple Myeloma | Phase 1 / Phase 2 | 2025-08-31 |
| Recruiting | A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis Allergic Rhinitis, Seasonal | Phase 3 | 2025-08-15 |
| Recruiting | GR1803 Injection in Patients With RRMM Multiple Myleoma | Phase 2 | 2025-04-24 |
| Active Not Recruiting | A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | 2024-09-19 |
| Recruiting | A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristi Tetanus | Phase 3 | 2024-09-03 |
| Recruiting | GR1803 Injection in Patients With Relapsed/Refractory Multiple Myeloma Multiple Myeloma | Phase 2 | 2024-08-26 |
| Active Not Recruiting | A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR). Allergic Rhinitis | Phase 2 | 2024-03-24 |
| Unknown | A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2102 in Healthy Adult Respiratory Syncytial Virus Infections | Phase 1 | 2024-03-23 |
| Unknown | Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis Atopic Dermatitis | Phase 3 | 2024-01-01 |
| Unknown | A Study to Evaluate the Safety and Efficacy of GR2002 Injection in Patients With Atopic Dermatitis. Atopic Dermatitis | Phase 1 | 2023-12-01 |
| Unknown | The Study of Long-term Outcomes of GR1802 in Patients With Chronic Rhinosinusitis With Nasal Polyps Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | 2023-08-18 |
| Completed | The Study of Single Dose Administration of GR2002 Injection in Chinese Health Volunteers Asthma | Phase 1 | 2023-06-16 |
| Completed | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 in Chinese Healthy Adult Tetanus | Phase 1 / Phase 2 | 2023-03-04 |
| Active Not Recruiting | The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps Chronic Rhinosinusitis with Nasal Polyps | Phase 2 | 2023-02-08 |
| Completed | Study to Evaluate GR1801's Efficacy and Safety Rabies Post-exposure Prophylaxis | Phase 3 | 2022-10-21 |
| Unknown | A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safet Asthma | Phase 2 | 2022-07-19 |
| Completed | Study of Efficacy and Safety of GR1501 in Patients with Radiographic Axial Spondyloarthritis Axial Spondyloarthritis | Phase 3 | 2022-06-13 |
| Completed | Phase I Trial of GR1803 Injection in Patients With RRMM Multiple Myeloma (MM) | Phase 1 / Phase 2 | 2022-05-27 |
| Active Not Recruiting | Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLE Lupus Erythematosus, Systemic | Phase 1 / Phase 2 | 2022-03-08 |
| Completed | to Evaluate the Preliminary Efficacy and Safety of GR1501 Injection in Patients With Active Axial Spondyloarth Axial Spondyloarthritis | Phase 2 | 2020-09-07 |